APA (7th ed.) Citation

A, M., C, L., S, S., A, M., F, M., & E, T. (2026). Regulatory discrepancies and patient-safety risks from the continued marketing of withdrawn medicines in Ecuador, Colombia, and Peru (2014-2025). Drug metabolism and personalized therapy. https://doi.org/10.1515/dmpt-2025-0081

Chicago Style (17th ed.) Citation

A, Miranda, Lopez C, Santos S, Moncayo A, Morales F, and Teran E. "Regulatory Discrepancies and Patient-safety Risks from the Continued Marketing of Withdrawn Medicines in Ecuador, Colombia, and Peru (2014-2025)." Drug Metabolism and Personalized Therapy 2026. https://doi.org/10.1515/dmpt-2025-0081.

MLA (9th ed.) Citation

A, Miranda, et al. "Regulatory Discrepancies and Patient-safety Risks from the Continued Marketing of Withdrawn Medicines in Ecuador, Colombia, and Peru (2014-2025)." Drug Metabolism and Personalized Therapy, 2026, https://doi.org/10.1515/dmpt-2025-0081.